Abstract
Multidrug resistance (MDR) seriously limits the efficacy of chemotherapy in patients with cancer and leukemia. Active transport across membranes is essential for such cellular drug resistance, largely provided by ATP-binding cassette (ABC) transport proteins. Intracellular drug sequestration contributes to MDR; however, a genuine intracellular ABC transport protein with MDR function has not yet been identified. Analyzing the intrinsic drug efflux capacity of leukemic stem cells, we found the ABC transporter A3 (ABCA3) to be expressed consistently in acute myeloid leukemia (AML) samples. Greater expression of ABCA3 is associated with unfavorable treatment outcome, and in vitro, elevated expression induces resistance toward a broad spectrum of cytostatic agents. ABCA3 remains localized within the limiting membranes of lysosomes and multivesicular bodies, in which cytostatics are efficiently sequestered. In addition to AML, we also detected ABCA3 in a panel of lymphohematopoietic tissues and transformed cell lines. In conclusion, we identified subcellular drug sequestration mediated by the genuinely intracellular ABCA3 as being a clinically relevant mechanism of intrinsic MDR.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tallman MS, Gilliland DG, Rowe JM . Drug therapy for acute myeloid leukemia. Blood 2005; 106: 1154–1163.
Fialkow PJ, Gartler SM, Yoshida A . Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci USA 1967; 58: 1468–1471.
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645–648.
Jordan CT, Guzman ML, Noble M . Cancer stem cells. N Engl J Med 2006; 355: 1253–1261.
Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC . Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797–1806.
Wulf GG, Wang RY, Kuehnle I, Weidner D, Marini F, Brenner MK et al. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 2001; 98: 1166–1173.
Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U et al. A distinct ‘side population’ of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004; 101: 14228–14233.
Norwood K, Wang RY, Hirschmann-Jax C, Andreeff M, Brenner MK, Goodell MA et al. An in vivo propagated human acute myeloid leukemia expressing ABCA3. Leuk Res 2004; 28: 295–299.
Wulf GG, Modlich S, Inagaki N, Reinhardt D, Schroers R, Griesinger F et al. ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport. Haematologica 2004; 89: 1395–1397.
Cheong N, Madesh M, Gonzales LW, Zhao M, Yu K, Ballard PL et al. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J Biol Chem 2006; 281: 9791–9800.
Yamano G, Funahashi H, Kawanami O, Zhao LX, Ban N, Uchida Y et al. ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett 2001; 508: 221–225.
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.
Simon SM, Schindler M . Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 1994; 91: 3497–3504.
Gottesman MM, Pastan I . Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385–427.
Juliano RL, Ling V . A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152–162.
Marie JP, Zittoun R, Sikic BI . Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78: 586–592.
Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS et al. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood 1999; 94: 1086–1099.
Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650–1654.
Hurwitz SJ, Terashima M, Mizunuma N, Slapak CA . Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. Blood 1997; 89: 3745–3754.
Altan N, Chen Y, Schindler M, Simon SM . Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 1998; 187: 1583–1598.
Klugbauer N, Hofmann F . Primary structure of a novel ABC transporter with a chromosomal localization on the band encoding the multidrug resistance-associated protein. FEBS Lett 1996; 391: 61–65.
Mulugeta S, Gray JM, Notarfrancesco KL, Gonzales LW, Koval M, Feinstein SI et al. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem 2002; 277: 22147–22155.
Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M . ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004; 350: 1296–1303.
Nagata K, Yamamoto A, Ban N, Tanaka AR, Matsuo M, Kioka N et al. Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles. Biochem Biophys Res Commun 2004; 324: 262–268.
Yasui K, Mihara S, Zhao C, Okamoto H, Saito-Ohara F, Tomida A et al. Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res 2004; 64: 1403–1410.
Efferth T, Gillet JP, Sauerbrey A, Zintl F, Bertholet V, de Longueville F et al. Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia. Mol Cancer Ther 2006; 5: 1986–1994.
Steinbach D, Gillet JP, Sauerbrey A, Gruhn B, Dawczynski K, Bertholet V et al. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res 2006; 12: 4357–4363.
Stahlman MT, Besnard V, Wert SE, Weaver TE, Dingle S, Xu Y et al. Expression of ABCA3 in developing lung and other tissues. J Histochem Cytochem 2007; 55: 71–83.
Acknowledgements
BC designed and performed research, and analyzed data; RK, UR and SC performed research; NC, NI and NB contributed vital new reagents; DW performed research; DR provided vital reagents; AZ analyzed data; SS, WK, FK and LT contributed vital reagents and analyzed data; GGW designed research, analyzed data and wrote the paper. We thank Birgit Juenemann and Boguslawa Sadowski of the flow cytometry core facility at the University of Goettingen and York Hildebrandt for technical assistance, as well as Andrew Entwistle for his editing and proofreading of thepaper. Financial support for this research was provided to GW from the Deutsche Jose-Carreras Leukaemiestiftung and to BC from the research funding program of the Faculty of Medicine, Georg-August-University Goettingen.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure/Conflict of Interest
None of the authors have any financial interest related to this work.
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Rights and permissions
About this article
Cite this article
Chapuy, B., Koch, R., Radunski, U. et al. Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration. Leukemia 22, 1576–1586 (2008). https://doi.org/10.1038/leu.2008.103
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.103
Keywords
This article is cited by
-
Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer
Cellular Oncology (2023)
-
Drug resistance: from bacteria to cancer
Molecular Biomedicine (2021)
-
Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica
Scientific Reports (2020)
-
Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance
Molecular Cancer (2019)
-
Revisiting the role of ABC transporters in multidrug-resistant cancer
Nature Reviews Cancer (2018)